Figure 2.
Dose distributions for a patient who received proton-beam therapy for a T3N2 adenocarcinoma of the right lower lobe in a prospective phase I trial. The contralateral lung is almost completely spared.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.